1. Home
  2. KOSS vs AYTU Comparison

KOSS vs AYTU Comparison

Compare KOSS & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koss Corporation

KOSS

Koss Corporation

N/A

Current Price

$3.16

Market Cap

32.8M

ML Signal

N/A

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

N/A

Current Price

$1.95

Market Cap

27.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KOSS
AYTU
Founded
1953
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.8M
27.4M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
KOSS
AYTU
Price
$3.16
$1.95
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $9.67
AVG Volume (30 Days)
21.8K
★ 23.1K
Earning Date
10-29-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.56
N/A
EPS
★ N/A
N/A
Revenue
$13,020,773.00
★ $27,632,080.00
Revenue This Year
N/A
$17.96
Revenue Next Year
N/A
$27.98
P/E Ratio
★ N/A
N/A
Revenue Growth
3.14
★ 277.47
52 Week Low
$3.18
$1.80
52 Week High
$5.10
$3.07

Technical Indicators

Market Signals
Indicator
KOSS
AYTU
Relative Strength Index (RSI) 27.89 44.96
Support Level N/A $1.94
Resistance Level $4.14 $2.34
Average True Range (ATR) 0.18 0.09
MACD -0.05 0.01
Stochastic Oscillator 4.20 25.00

Price Performance

Historical Comparison
KOSS
AYTU

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: